Trial intelligence / Profile preview

GERICO: Adjuvant Chemotherapy in Elderly Breast Cancer

NCT00424203Phase 2Completed

Sponsor
Unicancer
Start
Jan 2006
Primary completion
Jan 2008
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of doxorubicin in breast cancer, sponsored by Unicancer. Started Jan 2006; status: completed.

02

Drugs

doxorubicin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00424203.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00424203.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call